Literature DB >> 25539522

Duration of anticoagulation for venous thromboembolic events.

Nathaniel R Smilowitz1, Jessica L Mega1, Jeffrey S Berger2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25539522      PMCID： PMC4279444          DOI： 10.1161/CIRCULATIONAHA.114.010456

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  20 in total

1.  Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.

Authors:  L Pinede; J Ninet; P Duhaut; S Chabaud; S Demolombe-Rague; I Durieu; P Nony; C Sanson; J P Boissel
Journal:  Circulation       Date:  2001-05-22       Impact factor: 29.690

2.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study.

Authors:  M D Silverstein; J A Heit; D N Mohr; T M Petterson; W M O'Fallon; L J Melton
Journal:  Arch Intern Med       Date:  1998-03-23

3.  Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.

Authors:  Paul M Ridker; Samuel Z Goldhaber; Ellie Danielson; Yves Rosenberg; Charles S Eby; Steven R Deitcher; Mary Cushman; Stephan Moll; Craig M Kessler; C Gregory Elliott; Rolf Paulson; Turnly Wong; Kenneth A Bauer; Bruce A Schwartz; Joseph P Miletich; Henri Bounameaux; Robert J Glynn
Journal:  N Engl J Med       Date:  2003-02-24       Impact factor: 91.245

4.  Extended oral anticoagulant therapy after a first episode of pulmonary embolism.

Authors:  Giancarlo Agnelli; Paolo Prandoni; Cecilia Becattini; Mauro Silingardi; Maria Rita Taliani; Maddalena Miccio; Davide Imberti; Renzo Poggio; Walter Ageno; Enrico Pogliani; Fernando Porro; Pietro Zonzin
Journal:  Ann Intern Med       Date:  2003-07-01       Impact factor: 25.391

5.  Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

Authors:  Sam Schulman; Clive Kearon; Ajay K Kakkar; Sebastian Schellong; Henry Eriksson; David Baanstra; Anne Mathilde Kvamme; Jeffrey Friedman; Patrick Mismetti; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

6.  Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism.

Authors:  Clive Kearon; Jeffrey S Ginsberg; Michael J Kovacs; David R Anderson; Philip Wells; Jim A Julian; Betsy MacKinnon; Jeffrey I Weitz; Mark A Crowther; Sean Dolan; Alexander G Turpie; William Geerts; Susan Solymoss; Paul van Nguyen; Christine Demers; Susan R Kahn; Jeannine Kassis; Marc Rodger; Julie Hambleton; Michael Gent
Journal:  N Engl J Med       Date:  2003-08-14       Impact factor: 91.245

Review 7.  Treatment of venous thromboembolism.

Authors:  Philip S Wells; Melissa A Forgie; Marc A Rodger
Journal:  JAMA       Date:  2014-02-19       Impact factor: 56.272

8.  Apixaban for extended treatment of venous thromboembolism.

Authors:  Giancarlo Agnelli; Harry R Buller; Alexander Cohen; Madelyn Curto; Alexander S Gallus; Margot Johnson; Anthony Porcari; Gary E Raskob; Jeffrey I Weitz
Journal:  N Engl J Med       Date:  2012-12-08       Impact factor: 91.245

9.  Low-dose aspirin for preventing recurrent venous thromboembolism.

Authors:  Timothy A Brighton; John W Eikelboom; Kristy Mann; Rebecca Mister; Alexander Gallus; Paul Ockelford; Harry Gibbs; Wendy Hague; Denis Xavier; Rafael Diaz; Adrienne Kirby; John Simes
Journal:  N Engl J Med       Date:  2012-11-04       Impact factor: 91.245

10.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983
View more
  1 in total

1.  Clinical outcomes of prolonged anticoagulation with rivaroxaban after unprovoked venous thromboembolism.

Authors:  Jeffrey S Berger; Roger Seheult; François Laliberté; Concetta Crivera; Dominique Lejeune; Yongling Xiao; Jeff Schein; Patrick Lefebvre; Scott Kaatz
Journal:  Res Pract Thromb Haemost       Date:  2017-11-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.